1. Current and future clinical utilities of Parkinson's disease and dementia biomarkers: can they help us conquer the disease?. (2nd November 2019) Authors: Ho, Gilbert; Takamatsu, Yoshiki; Waragai, Masaaki; Wada, Ryoko; Sugama, Shuei; Takenouchi, Takato; Fujita, Masayo; Ali, Alysha; Hsieh, Mindy Hsin-I; Hashimoto, Makoto Journal: Expert review of neurotherapeutics Issue: Volume 19:Number 11(2019) Page Start: 1149 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Diabetes, inflammation, and the adiponectin paradox: Therapeutic targets in SARS-CoV-2. Issue 8 (August 2021) Authors: Ho, Gilbert; Ali, Alysha; Takamatsu, Yoshiki; Wada, Ryoko; Masliah, Eliezer; Hashimoto, Makoto Journal: Drug discovery today Issue: Volume 26:Issue 8(2021) Page Start: 2036 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Differential involvement of amyloidogenic evolvability in oligodendropathies; Multiple Sclerosis and Multiple System Atrophy. Issue 1 (31st December 2023) Authors: Wei, Jianshe; Ho, Gilbert; Masliah, Eliezer; Hashimoto, Makoto Journal: Prion Issue: Volume 17:Issue 1(2023) Page Start: 29 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Dual-therapy strategy for modification of adiponectin receptor signaling in aging-associated chronic diseases. Issue 6 (June 2018) Authors: Waragai, Masaaki; Ho, Gilbert; Takamatsu, Yoshiki; Shimizu, Yuka; Sugino, Hiromu; Sugama, Shuei; Takenouchi, Takato; Masliah, Eliezer; Hashimoto, Makoto Journal: Drug discovery today Issue: Volume 23:Issue 6(2018) Page Start: 1305 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Importance of adiponectin activity in the pathogenesis of Alzheimer's disease. Issue 8 (11th July 2017) Authors: Waragai, Masaaki; Ho, Gilbert; Takamatsu, Yoshiki; Sekiyama, Kazunari; Sugama, Shuei; Takenouchi, Takato; Masliah, Eliezer; Hashimoto, Makoto Journal: Annals of clinical and translational neurology Issue: Volume 4:Issue 8(2017) Page Start: 591 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Therapeutic Potential of α-Synuclein Evolvability for Autosomal Recessive Parkinson's Disease. (23rd November 2021) Authors: Wei, Jianshe; Ho, Gilbert; Takamatsu, Yoshiki; Masliah, Eliezer; Hashimoto, Makoto Other Names: Tan Eng King Academic Editor. Journal: Parkinson's disease Issue: Volume 2021(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Understanding Creutzfeldt-Jackob disease from a viewpoint of amyloidogenic evolvability. Issue 1 (1st January 2020) Authors: Hashimoto, Makoto; Ho, Gilbert; Takamatsu, Yoshiki; Wada, Ryoko; Sugama, Shuei; Waragai, Masaaki; Masliah, Eliezer; Takenouchi, Takato Journal: Prion Issue: Volume 14:Issue 1(2020) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗